Und dann auf "Zum Home-Bildschirm [+]".
Stöbern
genialokal zum Startbildschirm hinzufügen
Installieren Sie die genialokal App auf Ihrem Startbildschirm für einen schnellen Zugriff und eine komfortable Nutzung.
Installieren Sie die genialokal App auf Ihrem Startbildschirm für einen schnellen Zugriff und eine komfortable Nutzung.
Ihr gewünschter Artikel ist in 0 Buchhandlungen vorrätig - wählen Sie hier eine Buchhandlung in Ihrer Nähe aus:
Don’t miss the breathtaking sequel to the New York Times bestselling Never Ever After! Order now and receive the SPECIAL FIRST EDITION while supplies last—featuring a designed case cover under the jacket and illustrated endpapers, in addition to shiny foil and embossing. This must-have special edition is only available in the limited first printing. After the explosive events of Never Ever After, Yining flees the Iron Mountains with her unlikely allies, seeking the truth about her newfound powers amid the secrets surrounding her ancestral home. But with a traitorous queen ruling the Three Kingdoms from a stolen throne, nowhere is truly safe, and Yining must decide whom to trust to keep her family—and her heart—from harm. Praise for Never Ever After: “Rich and layered and deliciously transportive.” —Renée Ahdieh, #1 New York Times bestselling author of The Wrath & the Dawn “Tan has crafted a jewel of a fairy-tale retelling and each prism is lustrous with sinister wonder.” —Roshani Chokshi, New York Times bestselling author of the Gilded Wolves Trilogy “A lush and effervescent, masterfully crafted fantasy.” —Elizabeth Lim, New York Times bestselling author of Six Crimson Cranes “I absolutely adored it and cannot wait for the sequel!” —Allison Saft, #1 New York Times bestselling author of Wings of Starlight
Sue Lynn Tan is the award-winning author of Never Ever After, the Celestial Kingdom series, and Immortal. Her books have been translated into seventeen languages and are New York Times, USA Today, and Sunday Times bestsellers. Find her online at suelynntan.com or on Instagram @suelynntan.
